Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

REWIND Investigators

Research output: Contribution to journalArticlepeer-review

809 Scopus citations

Fingerprint

Dive into the research topics of 'Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences